US Patent Issued to NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE on Feb. 10 for "Compound having biological activity such as antiviral activity" (Japanese Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,671, issued on Feb. 10, was assigned to NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE (Tokyo).

"Compound having biological activity such as antiviral activity" was invented by Hiroaki Mitsuya (Tokyo), Hirokazu Tamamura (Tokyo) and Nobuyo Kuwata (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "A compound represented by the following general formula (1) that has an activity of suppressing a virus protease and an antiviral activity and has a low toxicity to a host cell:"

The patent was filed on July 14, 2022, under Application No. 17/928,746.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/net...